Senti Biosciences is trading 6.88% higher at $0.23 on October 29, 2026, with no clear company-specific catalyst identified.

  • This is the second consecutive daily gain, following a 15.21% rise on October 28.
  • Recent coverage discussed a director resignation and an October 30 record date for contingent value rights; neither was linked to the move.
  • The broader market was mixed to lower, offering no clear explanation for the stock’s rise.